The role of rasagiline in the treatment of Parkinson's disease.

Clinical interventions in aging

Volumn 5, Issue , 2010, Pages 149-156

  Leegwater Kim, Julie ^a   Bortan, Elena ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INDAN DERIVATIVE; MONOAMINE OXIDASE INHIBITOR; RASAGILINE;

AGED; DRUG INTERACTION; HUMAN; PARKINSON DISEASE; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT OUTCOME;

AGED; DRUG INTERACTIONS; HUMANS; INDANS; MONOAMINE OXIDASE INHIBITORS; PARKINSON DISEASE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 77955289403     PISSN: None     EISSN: 11781998     Source Type: Journal    
DOI: 10.2147/cia.s4145     Document Type: Review

References (61)